NO934381L - Therapeutic compositions for osteoinduction - Google Patents

Therapeutic compositions for osteoinduction

Info

Publication number
NO934381L
NO934381L NO934381A NO934381A NO934381L NO 934381 L NO934381 L NO 934381L NO 934381 A NO934381 A NO 934381A NO 934381 A NO934381 A NO 934381A NO 934381 L NO934381 L NO 934381L
Authority
NO
Norway
Prior art keywords
osteoinduction
therapeutic compositions
mammal
safe
effective amount
Prior art date
Application number
NO934381A
Other languages
Norwegian (no)
Other versions
NO934381D0 (en
Inventor
Roger Lee Stone
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO934381D0 publication Critical patent/NO934381D0/en
Publication of NO934381L publication Critical patent/NO934381L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

En fremgangsmåte for å generere ny benvekst i et pattedyr omfattende å administrere til pattedyret en sikker og effektiv mengde av en vitamin D-for-bindelse i kombinasjon med en sikker og effektiv mengde av et osteoinduktivt ekstrakt eller minst ett benmorfogent protein.A method of generating new bone growth in a mammal comprising administering to the mammal a safe and effective amount of a vitamin D compound in combination with a safe and effective amount of an osteoinductive extract or at least one bone morphogenic protein.

NO934381A 1991-06-05 1993-12-02 Therapeutic compositions for osteoinduction NO934381L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US85611092A 1992-03-27 1992-03-27
PCT/US1992/004356 WO1992021365A1 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Publications (2)

Publication Number Publication Date
NO934381D0 NO934381D0 (en) 1993-12-02
NO934381L true NO934381L (en) 1994-01-31

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934381A NO934381L (en) 1991-06-05 1993-12-02 Therapeutic compositions for osteoinduction

Country Status (13)

Country Link
EP (1) EP0587751A1 (en)
JP (1) JPH06508140A (en)
AU (1) AU667815B2 (en)
BR (1) BR9206110A (en)
CA (1) CA2110410C (en)
CZ (1) CZ282231B6 (en)
IE (1) IE921812A1 (en)
NO (1) NO934381L (en)
NZ (1) NZ243018A (en)
PT (1) PT100567A (en)
RU (1) RU2107512C1 (en)
SK (1) SK136693A3 (en)
WO (1) WO1992021365A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
ES2253736T3 (en) * 1991-08-30 2006-06-01 Curis, Inc. TREATMENT TO PREVENT LOSS AND / OR INCREASE THE OSEA MASS IN BONE METABOLIC DISORDERS.
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
KR960701648A (en) * 1993-03-29 1996-03-28 마크 제이. 머레이 Osteoblast growth composition containing PDGF and vitamin D (OESTEOBLAST GROWTH STIMULATING COMPOSTION CONTAINING PDGF AND VITAMIND)
JPH10505223A (en) * 1994-06-07 1998-05-26 クリエイティブ バイオモレキュールズ， インコーポレイテッド Methods and compositions for modulating morphogenic protein expression
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
WO1998034655A1 (en) * 1997-02-07 1998-08-13 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
KR20110032003A (en) * 2001-10-31 2011-03-29 알콘, 인코퍼레이티드 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
JP5444212B2 (en) * 2007-04-25 2014-03-19 シトクロマ インコーポレイテッド Method for treating vitamin D deficiency and deficiency
JP5819733B2 (en) * 2009-02-12 2015-11-24 ストライカー コーポレイションＳｔｒｙｋｅｒ Ｃｏｒｐｏｒａｔｉｏｎ Peripheral administration of TGF-β superfamily member-containing protein for systemic treatment of disorders and diseases
EP2396026A2 (en) * 2009-02-12 2011-12-21 Stryker Corporation Compositions and methods for minimally-invasive systemic delivery of proteins including tgf- superfamily members
RU2595804C1 (en) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Composition for producing dental therapeutic film

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Also Published As

Publication number Publication date
BR9206110A (en) 1995-07-11
AU667815B2 (en) 1996-04-18
IE921812A1 (en) 1992-12-16
EP0587751A1 (en) 1994-03-23
CZ282231B6 (en) 1997-06-11
NO934381D0 (en) 1993-12-02
AU2145492A (en) 1993-01-08
RU2107512C1 (en) 1998-03-27
PT100567A (en) 1994-01-31
CZ262493A3 (en) 1994-07-13
CA2110410A1 (en) 1992-12-10
WO1992021365A1 (en) 1992-12-10
SK136693A3 (en) 1994-10-05
JPH06508140A (en) 1994-09-14
NZ243018A (en) 1995-12-21
CA2110410C (en) 1997-04-15

Similar Documents

Publication Publication Date Title
NO934381L (en) Therapeutic compositions for osteoinduction
ES2033434T3 (en) COSMETIC COMPOSITION.
DK337888D0 (en) DESODORIZING AND ANTIMICROBIAL COMPOSITION FOR USE IN COSMETIC OR TOPICAL PREPARATIONS
SE8504967D0 (en) A PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATING THE BODY
DK0920309T3 (en) Conjugated linolenic acid to preserve or increase bone mineral content
LV12284A (en) Bioactive products were released from the tissues and contained pharmaceutical and cosmetic compositions
ES2149776T3 (en) MODULATION, INDUCED BY A MORPHOGEN, OF THE INFLAMMATORY RESPONSE.
RU93058532A (en) PHARMACEUTICAL COMPOSITION FOR OSTEOINDUCTION, METHOD FOR NEW BONE GENERATION
GR1002802B (en) Cosmetic compositions and skin treatment compositions
NL193399B (en) Injectable implant composition for use in reconstructive surgical treatments.
KR950702120A (en) USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS
MX9301387A (en) METHOD AND COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS.
FI961336A0 (en) Method for preserving ocular fluids and compositions for this purpose
SE8802869D0 (en) COMBINATION OF PYRAMIDINE DERIVATIVES AND RETONOIDS, AS SEPARATE COMPONENTS, FOR INDUCING AND STIMULATING HAIR GROWTH AND REDUCING ITS LOSS
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
HUT66153A (en) Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
ATE250860T1 (en) INCREASED STABILITY OF SOLID PREPARATIONS CONTAINING AZADIRACHTIN
SE8700156D0 (en) COSMETIC COMPOSITIONS WITH SKIN LYING AND SKIN GENERATING EFFECT AND PROCEDURE FOR PREPARING THEREOF
DK601888D0 (en) USE OF 2-PYRIMIDINYL-1-PIPERAZINE DERIVATIVES
SE8403659D0 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION
GR3024648T3 (en) Pharmaceutical preparation
DE69210286T2 (en) Treatment of intraocular pressure with a synergistic combination
MX9206135A (en) METHODS
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
DE69734349D1 (en) TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN